Spasticity treatment with botulinum toxins

Journal of Neural Transmission

Volumn 115, Issue 4, 2008, Pages 607-616

  Ward, A B ^a  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

Author keywords

Botulinum toxin; Management strategy for focal problems; Spasticity

Indexed keywords

BACLOFEN; BOTULINUM TOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; DANTROLENE; GABAPENTIN; PHENOL; PLACEBO; PREGABALIN; TIZANIDINE;

ALGORITHM; ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRACTURE; ECHOGRAPHY; ELECTROMYOGRAPHY; FUNCTIONAL ASSESSMENT; HEALTH CARE ORGANIZATION; HEALTH SERVICE; HEMIPLEGIA; HUMAN; MOTOR NEURON DISEASE; MUSCLE EXCITATION; NERVE CONDUCTION; PATIENT CARE; PHYSIOTHERAPY; PRIORITY JOURNAL; SPASTICITY; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT;

ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; HUMANS; MOTOR NEURON DISEASE; MUSCLE SPASTICITY;

EID: 42149110195     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0833-2     Document Type: Article

References (44)

1. AMO Bakheit AF Thilmann AB Ward W Poewe J Wissel J Muller R Benecke C Collin F Muller CD Ward C Neumann 2000 A randomised, double-blind, dose ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) in the treatment of upper limb spasticity after stroke Stroke 31 10 2402 2406
2. MP Barnes 1992 Neurological rehabilitation - a working party report of the British Society of Rehabilitation Medicine and the Neurological Alliance British Society of Rehabilitation Medicine London
3. BB Bhakta AA Cozens M Chamberlain JM Bamford 2000 Impact of botulinum toxin type A on disability and carer burden due to arm spasticity after stroke: a randomised, double-blind, placebo-controlled trial J Neurol Neurosurg Psychiatry 69 217 228
4. GE Borodic R Ferrante LB Pearce K Smith 1994 Histologic assessment of dose related diffusion and muscle fibre response after therapeutic botulinum A toxin injections Mov Disord 9 31 38
5. A Brashear MF Gordon E Elovic VD Kassicieh C Marciniak M Do CH Lee S Jenkins C Turkel the Botox Post-Stroke Spasticity Study Group 2002a Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke N Engl J Med 347 6 395 400
6. A Brashear R Zafonte M Corcoran N Galvez-Jimenez JM Gracies MF Gordon A McAfee K Ruffing B Thompson M Williams CH Lee C Turkel 2002b Inter- and intra-rater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb post-stroke spasticity Arch Phys Med Rehabil 83 10 1349 1354
7. MF Brin the Spasticity Study Group 1997 Etiology, evaluation and management of spasticity, and the role of botulinum toxin type A Muscle Nerve 6 S1 S232
8. P Burbaud L Wiart JL Dubos E Gaujard X Debelleix PA Joseph JM Mazaux B Bioulac M Barat A Lagueny 1996 A randomised double-blind placebo-controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients J Neurol Neurosurg Psychiatry 61 265 268
9. MK Childers DOM Stacy DL Cooke HH Stonnington 1996 Comparison of two injection techniques in spastic hemiplegia Am J Phys Med Rehabil 75 462 468
10. K Desloovere G Molenaers I Jonkers J De Cat L De Borre J Nijs M Eyssen P Pauwels P De Cock 2001 A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures Eur J Neurol 5 8 Suppl 75 87
11. JO Dolly K Aoki 2006 The structure and mode of action of botulinum toxins EurJ Neurol 4 13 Suppl 1 9
12. O Dolly 2003 Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins Headache 1 43 Suppl S16 S24
13. S Edwards 1996 Neurological physiotherapy: a problem solving approach Churchill Livingstone London 45 47
14. J Finsterer I Fuchs B Mamoli 1997 Automatic-guided botulinum toxin treatment of spasticity Clin Neuropharm 3 195 203
15. MF Gordon A Brashear E Elovic D Kassicieh C Marciniak J Liu C Turkel the BOTOX Post-stroke Spasticity Study Group 2004 Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke Neurology 63 10 1971 1973
16. JM Gracies 2004 Physiological effects of botulinum toxin in spasticity Mov Disord 8 19 Suppl S120 S128
17. JM Gracies L Wilson SC Gandevia D Burke 1997 Stretched position of spastic muscle aggravates their co-contraction in hemiplegic patients Ann Neurol 42 30 438 439
18. N Hyman M Barnes B Bhakta A Cozens M Bakheit B Kreczy-Kleedorfer W Poewe J Wissel P Bain S Glickman A Sayer A Richardson C Dott 2000 Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study J Neurol Neurosurg Psychiatry 68 6 707 712
19. GR Johnson 2001 Measurement of spasticity MP Barnes GR Johnson Upper motor neuron syndrome and spasticity: clinical management and Neurophysiology Cambridge University Press Cambridge 79 95
20. JW Lance 1980 Symposium synopsis RG Feldman RR Young WP Koella Spasticity: disordered control Yearbook Medical Chicago 485 494
21. RC Lyle 1981 A performance test for assessment of upper limb function in physical rehabilitation treatment and research Int J Rehabil Res 4 483 492
22. Mayer NH (2002) Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. In: Mayer NH, Simpson DM (eds) Spasticity: etiology, evaluation, management and the role of botulinum toxin. We Move, New York, pp 1-10
23. PA Mortenson JJ Eng 2003 The use of casts in the management of joint mobility and hypertonia following brain injury in adults: a systematic review Phys Ther 83 7 648 658
24. AD Pandyan GR Johnson CIM Price RH Curless MP Barnes H Rodgers 1999 A review of the properties and limitations of the Ashworth and modified Ashworth scales as measures of spasticity Clin Rehabil 13 373 383
25. AD Pandyan P Vuadens FM van Wijck S Stark GR Johnson MP Barnes 2002 Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox® to the elbow flexors in a unilateral stroke population Clin Rehabil 16 6 654 660
26. R Pellizzari O Rossetto G Schiavo C Montecucco 1999 Tetanus and botulinum neurotoxins: mechanism of action and therapeutic uses Phil Trans Royal Soc London Biol Sci 354 1381 259 268
27. F Reiter M Danni G Lagalla G Ceravalo L Provinciali 1998 Low dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke Arch Phys Med Rehabil 79 532 535
28. D Richardson G Sheean D Werring M Desai S Edwards R Greenwood A Thompson 2000 Evaluating the role of botulinum toxin in the management of focal hypertonia in adults J Neurol Neurosurg Psychiatry 69 499 506
29. DM Simpson DN Alexander CF O'Brien M Tagliati AS Aswad JM Leon J Gibson JM Mordaunt EP Monaghan 1996 Botulinum toxin type A in the treatment of upper extremity spasticity; a randomised, double-blind, placebo-controlled trial Neurology 46 1306 1310
30. Simpson DM (2008) Placebo-controlled double-blind trial of BOTOX® (botulinum toxin type A) versus Zanaflex® (tizanidine) for the treatment of upper limb spasticity. Personal communication
31. SPASM: A European Thematic Network to Develop Standardised Measures of Spasticity (2005) CREST - Centre for Rehabilitation and Engineering Studies, University of Newcastle, Stephenson Building, Claremont Road, Newcastle upon Tyne, NE1 7RU, U.K. Website available at: http://www.ncl.ac.uk/spasm/. Accessed September 20, 2007
32. G Tardieu S Shentoub R Delarue 1954 A la recherche d'une technique de measure de la spasticité Revue Neurologique 91 143 144
33. JC Tardieu C Tabary C Tardieu G Tardieu G Goldspink 1972 Physiological and structural changes in cat soleus muscle due to immobilization at different lengths by plaster casts J Physiol 224 231 244
34. C Tardieu A Lespargot C Tabary MD Bret 1988 For how long must the soleus muscle be stretched each day to prevent contracture? Dev Med Child Neurol 30 3 10
35. L Turner-Stokes AB Ward 2002 The management of adult spasticity using botulinum toxin type A - a guide to clinical practice Clin Med 2 2 128 130
36. D Verplancke S Snape CF Salisbury PW Jones AB Ward 2005 A randomised controlled trial of the management of early lower limb spasticity following acute acquired severe brain injury Clin Rehabil 19 2 117 125
37. DT Wade 1992 Measurement in neurological rehabilitation Oxford University Press Oxford
38. AB Ward 1999a Botulinum toxin in spasticity management Brit J Ther Rehabil 6 7 26 34
39. AB Ward 1999b Use of botulinum toxin type A in spastic diplegia resulting from cerebral palsy Eur J Neurol 4 6 Suppl S46 S48
40. Ward AB, (2001) Working party report on the management of adult spasticity using botulinum toxin type A - a guide to clinical practice. Radius Healthcare, Byfleet
41. AB Ward 2002 A summary of spasticity management - a treatment algorithm Eur J Neurol 1 9 Suppl 48 52
42. AB Ward M Aguilar Z de Beyl S Gedin P Kanovsky F Molteni J Wissel A Yakovleff 2003 The use of botulinum toxin type A in the management of adult spasticity - a European consensus statement J Rehabil Med 35 2 98 99
43. R Wartenburg 1951 Pendulousness of the legs as a diagnostic test Neurology 1 18 24
44. RR Young 1994 Spasticity: a review Neurology 44 512 520